Zeus
Global leader in mission-critical components for lifesaving medical procedures
Zeus uses its material science expertise to design and manufacture advanced polymer components and catheter solutions for the world’s most innovative medical device and industrial companies
- SectorHealthcare
- CountryUnited States
- Responsible AdvisorEthan Waxman
- FundEQT X
- Entry2024
- Web
Zeus is a pioneer in the design, development, and extrusion of fluoropolymer tubing for medical devices and select industrial applications.
Founded in 1966 by the Tourville family, the company is headquartered in Orangeburg, South Carolina, with eight facilities across the United States and one in Letterkenny, Ireland. Zeus employs 2,400 people globally and serves over 300 customers in more than 100 countries, including leading medical device manufacturers, contract device manufacturing organizations, academic institutions, and industrial customers across aerospace, semiconductors, and automotive, among other industries.
Market Trends and Drivers
Zeus’ components enable the delivery of minimally invasive interventional procedures, which drive significantly better health outcomes than traditional open surgeries, including faster patient recovery and reduced pain, at lower cost.
As populations age and chronic conditions become more prevalent, increasing demand for precision, high-performance catheters to support therapeutic areas including structural heart, peripheral and neurovascular interventions, is expected to continue fueling Zeus’ growth.
Investment Potential
EQT will support Zeus’ growth with investments in additional capacity, R&D, and operational excellence. These investments will enable the company to continue partnering with its clients’ research and development groups to remain at the forefront of next generation technologies.
Board of directors
- ChairpersonJohn Groetelaars
- Board memberKevin Ballinger
- Board memberEthan Waxman
- Board memberEric Liu